Bruker Corporation - Common Stock (BRKR)

Bruker’s third quarter drew a positive response from the market, as the company delivered a notable step-up in profitability despite only modest topline grow...

Cost cuts lifted margins, but a segment write-down clouded the quarter.

What happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR) jumped 10.9% in the afternoon session after the company reported third quarter 20...

Bruker (NASDAQ:BRKR) reported third-quarter 2026 revenue growth of 1.6% to $874 million, while non-GAAP earnings per share rose 24.4% year over year to $0.56 as cost-saving actions and favorable product mix supported margin expansion. Organic revenue increased 0.7% in the quarter. Acquisitions cont

Scientific instrument company Bruker (NASDAQ:BRKR) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 1.6% year on year to...

Scientific instrument company Bruker (NASDAQ:BRKR) will be reporting results this Wednesday morning. Here’s what to expect. Bruker missed analysts’ revenue e...

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...

Bruker has been on fire lately. In the past six months alone, the company’s stock price has rocketed 50.7%, reaching $58.84 per share. This run-up might have...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...

Bruker (NASDAQ:BRKR) CFO Gerald Herman said the company’s second-quarter results reflected stronger-than-expected organic order bookings and earnings per share, while revenue came in later than anticipated. He attributed the revenue timing primarily to a mixed demand environment and shipment timing,

What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR) fell 6.3% in the afternoon session after UBS initiated coverage on the stock with...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Let’s dig into the relative performance of Bruker (NASDAQ:BRKR) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season...

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

Semiconductor metrology and energy research orders surge over 50% organically.

Bruker’s second quarter results prompted a significant negative market reaction, with shares declining sharply following the release. Management identified s...

Scientific instrument company Bruker (NASDAQ:BRKR) missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 5.2% year on year to $838.5 million...

What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR) fell 17.7% in the morning session after the company reported second-quarter resul...

Bruker (NASDAQ:BRKR) reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research. Second-quarter reported revenue

Scientific instrument company Bruker (NASDAQ:BRKR) missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 5.2% year on year to $838.5 million...

Scientific instrument company Bruker (NASDAQ:BRKR) will be announcing earnings results this Tuesday before market open. Here’s what to look for. Bruker beat ...

Bruker’s 26.8% return over the past six months has outpaced the S&P 500 by 20.6%, and its stock price has climbed to $60.45 per share. This was partly thanks...